These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18652078)

  • 1. Clinical use of creatine in neuromuscular and neurometabolic disorders.
    Tarnopolsky MA
    Subcell Biochem; 2007; 46():183-204. PubMed ID: 18652078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.
    Tarnopolsky MA; Mahoney DJ; Vajsar J; Rodriguez C; Doherty TJ; Roy BD; Biggar D
    Neurology; 2004 May; 62(10):1771-7. PubMed ID: 15159476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial creatine sensitivity is lost in the D2.
    Bellissimo CA; Delfinis LJ; Hughes MC; Turnbull PC; Gandhi S; DiBenedetto SN; Rahman FA; Tadi P; Amaral CA; Dehghani A; Cobley JN; Quadrilatero J; Schlattner U; Perry CGR
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1141-C1157. PubMed ID: 36689672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine as a therapeutic strategy for myopathies.
    Tarnopolsky MA
    Amino Acids; 2011 May; 40(5):1397-407. PubMed ID: 21399918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
    J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
    Tarnopolsky M; Mahoney D; Thompson T; Naylor H; Doherty TJ
    Muscle Nerve; 2004 Jan; 29(1):51-8. PubMed ID: 14694498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study.
    Felber S; Skladal D; Wyss M; Kremser C; Koller A; Sperl W
    Neurol Res; 2000 Mar; 22(2):145-50. PubMed ID: 10763500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults.
    Brose A; Parise G; Tarnopolsky MA
    J Gerontol A Biol Sci Med Sci; 2003 Jan; 58(1):11-9. PubMed ID: 12560406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth neuropathy type 1A combined with Duchenne muscular dystrophy.
    Vondracek P; Hermanova M; Sedlackova J; Fajkusova L; Stary D; Michenkova A; Gaillyova R; Seeman P; Mazanec R
    Eur J Neurol; 2007 Oct; 14(10):1182-5. PubMed ID: 17880576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
    Banerjee B; Sharma U; Balasubramanian K; Kalaivani M; Kalra V; Jagannathan NR
    Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine monohydrate as a therapeutic aid in muscular dystrophy.
    Pearlman JP; Fielding RA
    Nutr Rev; 2006 Feb; 64(2 Pt 1):80-8. PubMed ID: 16536185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and nutritional treatment for McArdle's disease (Glycogen Storage Disease type V).
    Quinlivan R; Beynon RJ
    Cochrane Database Syst Rev; 2004; (3):CD003458. PubMed ID: 15266486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in neuromuscular disorders.
    Katsetos CD; Koutzaki S; Melvin JJ
    Semin Pediatr Neurol; 2013 Sep; 20(3):202-15. PubMed ID: 24331362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.